Long Journey of Sclerosant From the Esophagus to the Right Atrium.
10.4070/kcj.2010.40.9.468
- Author:
Jin Sun PARK
1
;
Jin Ju PARK
;
Seung Kwan LIM
;
Byoung Joo CHOI
;
So Yeon CHOI
;
Myeong Ho YOON
;
Gyo Seung HWANG
;
Seung Jea TAHK
;
Joon Han SHIN
Author Information
1. Department of Cardiology, Ajou University School of Medicine, Suwon, Korea. shinjh@ajou.ac.kr
- Publication Type:Case Report
- Keywords:
N-butyl-2-cyanoacrylate;
Esophageal varix;
Sclerotherapy;
Embolism;
Right atrium
- MeSH:
Adult;
Echocardiography;
Embolism;
Enbucrilate;
Esophageal and Gastric Varices;
Esophagus;
Ethiodized Oil;
Heart Atria;
Hemorrhage;
Humans;
Sclerotherapy;
Vena Cava, Inferior
- From:Korean Circulation Journal
2010;40(9):468-470
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 34-year-old man, who had been treated with an endoscopic injection of a mixture of n-butyl-2-cyanoacrylate (Histoacryl) and Lipiodol for control of variceal bleeding 6 months previously, presented with an intracardiac mass in the right atrium (RA). Two-dimensional echocardiography revealed an intracardiac mass in the RA that appeared to extend from the inferior vena cava. The origin of the sclerosant was traced by computed tomography (CT). This is a very rare case in which the sclerosant migration route was demonstrated by CT scan. The findings of this case suggest that the systemic migration of sclerosant into an intracardiac chamber should be considered in patients with an intracardiac mass, especially with a history of previous sclerotherapy for variceal bleeding.
